JPMORGAN CHASE & CO - SUMMIT THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 21 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$34,000
-59.5%
15,144
+132.6%
0.00%–
Q1 2018$84,000
+663.6%
6,511
+544.0%
0.00%–
Q4 2017$11,000–1,011–0.00%–
 Download
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
Worth Asset Management, LLC 10,956$20,4880.02%
Lindbrook Capital, LLC 782$1,4620.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders